Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: The Cancer and Leukemia Group B (study 9730).
      Google Scholar   
Citation:
J Clin Oncol vol 23 (1) 190-6
Year:
2005
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
 
Grants:
CA03927, CA04457, CA11789, CA12046, CA21060, CA31946, CA32291, CA33601, CA41287, CA45564, CA52784, CA77651  
Corr. Author:
 
Authors:
                           
Networks:
 
Study
CALGB-9730
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Phytogenic, Antineoplastic Combined Chemotherapy Protocols, Carboplatin, Carcinoma, Non-Small-Cell Lung, Female, Humans, Lung Neoplasms, Male, Middle Aged, Paclitaxel, Survival Rate